Fortune April 29, 2024
Matthew Perrone, The Associated Press

Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.

The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.

“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Provider
Neuralink gets FDA OK for 2nd patient
The ins and outs of cannabis
FDA Approves First Interchangeable Biosimilars to Eylea
Who distrusts the FDA? Survey shows gender, location and politics are key factors
FDA approves Amgen drug for tough-to-treat form of lung cancer

Share This Article